Atlas Trials

Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy Volunteers

Clinical trial NCT03894124 · COMPLETED

Trial details

NCT number
NCT03894124
Sponsor
Chelsea and Westminster NHS Foundation Trust
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Human Immunodeficiency Virus
Start date
2019-06-12
Primary completion
2019-07-25
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.